Form 8-K - Current report:
SEC Accession No. 0001493152-24-050216
Filing Date
2024-12-16
Accepted
2024-12-16 16:10:26
Documents
15
Period of Report
2024-12-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 71181
2 ex4-3.htm EX-4.3 9410
3 ex99-1.htm EX-99.1 8593
  Complete submission text file 0001493152-24-050216.txt   272562

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ogen-20241211.xsd EX-101.SCH 3018
5 XBRL LABEL FILE ogen-20241211_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE ogen-20241211_pre.xml EX-101.PRE 24167
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3699
Mailing Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236
Business Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 241551895
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)